Increased Non-Homologous End Joining Makes DNA-PK a Promising Target for Therapeutic Intervention in Uveal Melanoma
Uveal melanoma (UM) is the most common primary intraocular tumour in adults, with a mean survival of six months following metastasis. The survival rates have not improved in over 30 years. This study has shown that sister chromatid exchange (SCE) is low in UM which is likely due to a reduced express...
Main Authors: | Rachel E. Doherty, Helen E. Bryant, Manoj K. Valluru, Ian G. Rennie, Karen Sisley |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/9/1278 |
Similar Items
-
The Prognostic Values of PARP-1 Expression in Uveal Melanoma
by: Malgorzata Gajdzis, et al.
Published: (2021-01-01) -
PARP Inhibition Increases the Response to Chemotherapy in Uveal Melanoma
by: Leanne de Koning, et al.
Published: (2019-05-01) -
Telomere-Internal Double-Strand Breaks Are Repaired by Homologous Recombination and PARP1/Lig3-Dependent End-Joining
by: Ylli Doksani, et al.
Published: (2016-11-01) -
Differential Expression of DNA Repair Genes in Prognostically-Favorable versus Unfavorable Uveal Melanoma
by: Mehmet Dogrusöz, et al.
Published: (2019-08-01) -
Dual mTOR/DNA-PK Inhibitor CC-115 Induces Cell Death in Melanoma Cells and Has Radiosensitizing Potential
by: Felix Bürkel, et al.
Published: (2020-12-01)